par Demols, Anne 
;Rocq, Laureen ;Perez-Casanova Garcia, Luis;Charry, Manon;De Nève, Nancy;Ramadhan, Ali Mohammed ;Van Campenhout, Claude ;De Clercq, Sarah ;Maris, Calliope ;Closset, Jean ;Lucidi, Valerio ;Salmon, Isabelle ;D'Haene, Nicky
Référence The oncologist, 28, 7, page (e520-e525)
Publication Publié, 2023-07-01
;Rocq, Laureen ;Perez-Casanova Garcia, Luis;Charry, Manon;De Nève, Nancy;Ramadhan, Ali Mohammed ;Van Campenhout, Claude ;De Clercq, Sarah ;Maris, Calliope ;Closset, Jean ;Lucidi, Valerio ;Salmon, Isabelle ;D'Haene, Nicky Référence The oncologist, 28, 7, page (e520-e525)
Publication Publié, 2023-07-01
Article révisé par les pairs
| Résumé : | It is of interest to determine the incidence and molecular characteristics of NTRK gene fusions in patients with bilio-pancreatic cancers, because of possible treatment with TRK inhibitors for advanced tumors. The aim of the present study was to apply the guidelines for NTRK testing algorithm to a series of patients with bilio-pancreatic cancers. |
